We and others have previously shown that a breakthrough infection (BTI) with a VOC following vaccination can broaden the neutralization capacity of the polyclonal response in sera, and generate neutralizing activity against highly divergent SARS-CoV-2 viral variants carrying Spike mutations across multiple neutralizing epitopes (19, –, 23). This evidence concerns the gene CHMP5 and infection.